Market headlines Moderna (MRNA) is seeing renewed investor interest due to improved revenue trends and upcoming product launches. However, the company faces challenges in diversifying beyond COVID-19 ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the lawsuits ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with regulatory ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Join makers, innovators, and leaders as we explore how apps, agents, and Copilot are transforming work and powering the rise of AI-powered Frontier Firms. The 2025 release wave 2 for Microsoft ...